ANDA > Nova Content
Before Wallach, Clevenger, and Stoll. Appeal from the United States District Court for the District of Delaware.
Summary: Regulatory guidelines... Read More »
Before Moore, Wallach, and Hughes. Appeal from the Patent Trial and Appeal Board
Summary: Industry skepticism is a question of fact that weighs... Read More »
Before Judges Reyna, Taranto, and Chen. Appeal from the U.S. District Court for the District of New Jersey.
Summary: There may be no reasonable expectation of... Read More »
Before Wallach, Clevenger, and Stoll. Appeal from the United States District Court for the District of Delaware.
Summary: Claims directed to a... Read More »
Federal Circuit Summary
Before Prost, Dyk, and Moore. Appeal from District of Delaware.
Summary: A district court’s... Read More »
Federal Circuit Summary
Before Lourie, O’Malley, Reyna. Appeals from the Patent Trial and Appeal Board, United States District Court for the Northern... Read More »
Federal Circuit Summary
Before Newman, Dyk, and Chen. Appeal from the Patent Trial and Appeal Board.
Summary: An injury-in-fact is required to establish ... Read More »
Federal Circuit Summary
Before Lourie, Bryson, and Wallach. Appeal from the Patent Trial and Appeal Board.
Summary: A party... Read More »
Federal Circuit Summary
Before Lourie, Chen, and Stoll. Appeal from the Patent Trial and Appeal Board.
Summary: A generic pharmaceutical ... Read More »
Federal Circuit Summary
Before Prost, Wallach, and Chen. Appeal from the United States District Court for the District of... Read More »
Federal Circuit Summary
Before Moore, Chen, and Hughes. Appeal from the United States District Court for the District of Delaware.
... Read More »
Federal Circuit Summary
Before Judges Reyna, Bryson, and Stoll. Appeals from the Patent Trial and Appeal Board and the United States... Read More »
Federal Circuit Summary
Before O’Malley, Reyna, and Hughes. Appeal from the District Court for the Northern District of California... Read More »
Federal Circuit Summary
Before Newman, Dyk, and Taranto. Appeal from the United States District Court for the District of Delaware.
Summary: ... Read More »
Federal Circuit Summary
Before Newman, Hughes, and Stoll. Appeal from the United States District Court for the District of Delaware
Summary: Objective indicia ... Read More »
On July 20, 2018, the Federal Circuit held that tribal sovereign immunity is not available as a defense in IPR.
Allergan Pharmaceuticals owned patents that it had ... Read More »
Federal Circuit Summary
Before Dyk, Moore, and Reyna. Appeal from the Patent Trial and Appeal Board.
Summary: Tribal sovereign immunity does not shield... Read More »
Federal Circuit Summary
Before Moore, Linn, and Chen. Appeal from the United States District Court for the District of Delaware.
Summary: A prior art... Read More »
Federal Circuit Summary
Before Newman, Lourie, and Reyna. Appeal from the Patent Trial and Appeal Board.
Summary: References were sufficiently... Read More »
On June 25th, 2018, the U.S. Food and Drug Administration (FDA) approved the drug, Epidiolex, for the treatment of seizures associated with two rare forms of... Read More »
